bf/NASDAQ:IKNA_icon.jpeg

NASDAQ:IKNA

Ikena Oncology

  • Stock

USD

Last Close

1.43

25/07 22:02

Market Cap

78.18M

Beta: 0.75

Volume Today

123K

Avg: 63.66K

PE Ratio

−0.98

PFCF: −0.87

OverviewFinancialsAPI

    Description

    Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small mole...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2.5-2-1.5-1-0.52019-12-302020-12-312022-03-172023-05-152024-08-082025-08-06

    Revenue (Estimate*)

    5M10M15M20M2019-12-302020-12-312022-03-172023-05-152024-08-082025-08-06

    *Estimate based on analyst consensus